Annual EBITDA
$3.86B$189.00M+5.16%
Summary
- Current Value
- As of today, ZTS annual EBITDA is $3.86B, up +5.16% on
- Historical Performance
- ZTS annual EBITDA is up +21.99% over the past 3 years, and up +58.25% over the past 5 years
- All-Time High Comparison
- ZTS annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ZTS annual EBITDA is +15.35% above its 3-year low of $3.34B reached on an earlier date
- Sector Comparison
- ZTS annual EBITDA is higher than 97.54% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $3.86B | +5.2% | +22.0% | +58.3% | +10000.0% | |
| Quarterly EBITDA | $1.06B | +1.8% | +26.5% | +36.8% | +427.4% | |
| TTM EBITDA | $4.03B | +4.9% | +22.1% | +49.2% | +1902.5% | |
| Price | $125.67 | -23.9% | -14.9% | -25.3% | – | |
| PE Ratio | 21.17 | -29.9% | -35.6% | -56.9% | – | |
| Annual Revenue | $9.26B | +8.3% | +19.0% | +47.9% | +235.4% | |
| Annual EPS | $5.47 | +7.8% | +27.9% | +75.5% | +2832.8% | |
| Annual EBIT | $3.36B | +5.8% | +23.8% | +65.9% | +2852.5% | |
| Annual Net Income | $2.50B | +6.7% | +22.7% | +66.4% | +2571.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $3.86B | at high | |
| 5Y | $3.86B | at high | |
| All | $3.86B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $3.34B | N/A | +15.3% |
| 5Y | $2.67B | N/A | +44.5% |
| All | $2.00M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of ZTS?
As of today, ZTS annual EBITDA is $3.86B
What is 1-year change in ZTS annual EBITDA?
ZTS annual EBITDA is up +5.16% year-over-year
What is 3-year change in ZTS annual EBITDA?
ZTS annual EBITDA is up +21.99% over the past 3 years
How far is ZTS annual EBITDA from its all-time high?
ZTS annual EBITDA is currently at its all-time high
How does ZTS annual EBITDA rank versus sector peers?
ZTS annual EBITDA is higher than 97.54% of companies in Healthcare sector
When is ZTS next annual earnings release?
The next annual earnings release for ZTS is on
Quarterly EBITDA
$1.06B$52.00M-4.68%
Summary
- Current Value
- As of today, ZTS quarterly EBITDA is $1.06B, down -4.68% on
- Historical Performance
- ZTS quarterly EBITDA is up +1.83% year-over-year, and up +26.49% over the past 3 years
- All-Time High Comparison
- ZTS quarterly EBITDA is currently -4.68% below its historical high of $1.11B set on
- 3-Year Low Comparison
- ZTS quarterly EBITDA is +31.03% above its 3-year low of $809.00M reached on an earlier date
- Sector Comparison
- ZTS quarterly EBITDA is higher than 97.20% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.06B | -4.7% | +1.8% | +26.5% | +36.8% | |
| Annual EBITDA | $3.86B | – | +5.2% | +22.0% | +58.3% | |
| TTM EBITDA | $4.03B | +0.5% | +4.9% | +22.1% | +49.2% | |
| Price | $125.67 | -12.4% | -23.9% | -14.9% | -25.3% | |
| PE Ratio | 21.17 | -12.4% | -29.9% | -35.6% | -56.9% | |
| Quarterly Revenue | $2.40B | -2.4% | +0.5% | +19.9% | +34.4% | |
| Quarterly EPS | $1.63 | +0.9% | +8.2% | +44.3% | +62.5% | |
| Quarterly EBIT | $936.00M | -5.4% | +1.7% | +29.5% | +41.0% | |
| Quarterly Net Income | $721.00M | +0.4% | +4.2% | +36.5% | +50.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.11B | -4.7% | |
| 3Y | $1.11B | -4.7% | |
| 5Y | $1.11B | -4.7% | |
| All | $1.11B | -4.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $888.00M | N/A | +19.4% |
| 3Y | $809.00M | N/A | +31.0% |
| 5Y | $622.00M | N/A | +70.4% |
| All | $191.00M | +455.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ZTS?
As of today, ZTS quarterly EBITDA is $1.06B
What is ZTS quarterly EBITDA most recent change?
ZTS quarterly EBITDA was down -4.68% on September 30, 2025
What is 1-year change in ZTS quarterly EBITDA?
ZTS quarterly EBITDA is up +1.83% year-over-year
How far is ZTS quarterly EBITDA from its all-time high?
ZTS quarterly EBITDA is currently -4.68% below its historical high of $1.11B set on June 30, 2025
How does ZTS quarterly EBITDA rank versus sector peers?
ZTS quarterly EBITDA is higher than 97.20% of companies in Healthcare sector
When is ZTS next earnings release?
The next earnings release for ZTS is on
TTM EBITDA
$4.03B$19.00M+0.47%
Summary
- Current Value
- As of today, ZTS TTM EBITDA is $4.03B, up +0.47% on
- Historical Performance
- ZTS TTM EBITDA is up +4.93% year-over-year, and up +22.08% over the past 3 years
- All-Time High Comparison
- ZTS TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ZTS TTM EBITDA is +20.58% above its 3-year low of $3.34B reached on
- Sector Comparison
- ZTS TTM EBITDA is higher than 97.11% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.03B | +0.5% | +4.9% | +22.1% | +49.2% | |
| Annual EBITDA | $3.86B | – | +5.2% | +22.0% | +58.3% | |
| Quarterly EBITDA | $1.06B | -4.7% | +1.8% | +26.5% | +36.8% | |
| Price | $125.67 | -12.4% | -23.9% | -14.9% | -25.3% | |
| PE Ratio | 21.17 | -12.4% | -29.9% | -35.6% | -56.9% | |
| TTM Revenue | $9.40B | +0.1% | +2.7% | +17.4% | +43.6% | |
| TTM EPS | $5.94 | +2.1% | +11.6% | +35.6% | +70.9% | |
| TTM EBIT | $3.54B | +0.5% | +6.0% | +24.8% | +56.7% | |
| TTM Net Income | $2.65B | +1.1% | +8.7% | +28.4% | +59.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.03B | at high | |
| 3Y | $4.03B | at high | |
| 5Y | $4.03B | at high | |
| All | $4.03B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.89B | N/A | +3.5% |
| 3Y | $3.34B | +20.6% | |
| 5Y | $2.71B | N/A | +48.5% |
| All | $201.00M | +1902.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ZTS?
As of today, ZTS TTM EBITDA is $4.03B
What is ZTS TTM EBITDA most recent change?
ZTS TTM EBITDA was up +0.47% on September 30, 2025
What is 1-year change in ZTS TTM EBITDA?
ZTS TTM EBITDA is up +4.93% year-over-year
How far is ZTS TTM EBITDA from its all-time high?
ZTS TTM EBITDA is currently at its all-time high
How does ZTS TTM EBITDA rank versus sector peers?
ZTS TTM EBITDA is higher than 97.11% of companies in Healthcare sector
When is ZTS next earnings release?
The next earnings release for ZTS is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ZTS Official Website www.zoetis.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1555280/000155528025000274/0001555280-25-000274-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1555280/000155528025000102/0001555280-25-000102-index.htm
- ZTS Profile on Yahoo Finance finance.yahoo.com/quote/ZTS
- ZTS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/zts